kabutan

ADR120S,Inc.(3750) Summary

3750
TSE Standard
ADR120S,Inc.
883
JPY
-3
(-0.34%)
Mar 13, 3:30 pm JST
5.53
USD
Mar 13, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
111.0
PBR
78.1
Yield
ー%
Margin Trading Ratio
Stock Price
Mar 13, 2026
Opening Mar 13, 9:00 am
883 JPY 5.54 USD
Previous Close Mar 12
886 JPY 5.57 USD
High Mar 13, 9:00 am
883 JPY 5.54 USD
Low Mar 13, 9:43 am
881 JPY 5.52 USD
Volume
2,000
Trading Value
2.00M JPY 0.01M USD
VWAP
882.5 JPY 5.52 USD
Minimum Trading Value
88,300 JPY 553 USD
Market Cap
7.88B JPY 0.05B USD
Number of Trades
15
Liquidity & Number of Trades
As of Mar 13, 2026
Liquidity
Slightly Low
1-Year Average
39
1-Year High Apr 2, 2025
1,257
Margin Trading
Date Short Interest Long Margin Positions Ratio
Mar 6, 2026 0 1,951,200
Feb 27, 2026 0 1,951,400
Feb 20, 2026 0 1,951,500
Feb 13, 2026 0 1,952,100
Feb 6, 2026 0 1,952,200
Company Profile
Cytori Cell Research Institute, Inc. has shifted its focus to regenerative medicine, medical devices, and medical tourism as its main business areas. The company is withdrawing from real estate and hotel operations.
Sector
Information & Communication
Cytori Cell Research Institute, Inc. is developing a medical business that invests in medical assets. The company sells medical devices such as Celution centrifuges and cell therapy kits to domestic medical institutions and university hospitals. In 2022, the company obtained domestic manufacturing and sales approval for the Celution Cell Therapy Kit, a highly controlled medical device, as a treatment for male stress urinary incontinence. Cytori Cell Research Institute, Inc. is withdrawing from real estate and hotel businesses, concentrating its management resources on the medical field.